Fate Trial Disclosure

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

• Bronchial neuroendocrine tumor→
• T-cell prolymphocytic leukemia→
• Malignant epithelial tumor of ovary→
• Plasma cell leukemia→
• Indolent B-cell non-Hodgkin lymphoma→
• Acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent→
• Adult hepatocellular carcinoma→
• Adenocarcinoma of the cervix uteri→
• NK-cell enteropathy→

Clinical trials (10)

• NCT03841110
• NCT04023071
• NCT04106167
• NCT05069935
• NCT04551885
• NCT05934097
• NCT05395052
• NCT04614636
• NCT04629729
• NCT04245722

Verify independently

• ClinicalTrials.gov PI search for Fate Trial Disclosure

Other specialists for Bronchial neuroendocrine tumor

Peers ranked by clinical-trial PI role, publications, and verification quality.

• Matthew Krebs, Dr
  The Christie Hospital
• Global Clinical Leader
  Daiichi Sankyo
• Andrea B Apolo, M.D., MD
  National Cancer Institute (NCI)
  MD
• Study Official
  Genmab
• Steven A Rosenberg, M.D.
  National Cancer Institute (NCI)
• Dawn Pinchasik, MD, M.D
  TScan Therapeutics, Inc.
  PA
• James L Gulley, M.D., MD PhD FACP
  National Cancer Institute (NCI)
  MD
• Pasi A Janne, MD, PhD, MD PHD
  Dana-Farber Cancer Institute
  MA

See all specialists for Bronchial neuroendocrine tumor →